1. Hauptnavigation
  2. Navigation des Hauptbereiches
  3. Inhalt der Seite

Press Officer and Head of Press and Public Relations

Dr. Stefanie Seltmann
Dr. Stefanie Seltmann

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.seltmann@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 19 | 20. May 2015 | by Sel

World No Tobacco Day 2015 – Put an end to the illicit trade of tobacco products

World No Tobacco Day 2015 – Put an end to the illicit trade of tobacco products

For World No Tobacco Day 2015, the World Health Organization (WHO) is calling on countries to band together to stop tobacco smuggling. An important political tool for achieving this goal is the Protocol to Eliminate Illicit Trade in Tobacco Products. For this year’s World No Tobacco Day, the German Cancer Research Center (Deutsches Krebsforschungszentrum - DKFZ) will publish an official German version of the protocol, with the goal of raising awareness to policy makers and the public about its value as a tool for combating illicit trade. DKFZ also aims to encourage policy makers to ratify the protocol, since 40 parties that have signed the protocol will also have to ratify it in order to implement effective enforcement strategies.

No. 18c | 12. May 2015 | by Koh

Epigenetic profiles allow for more precise predictions in brain cancer

Epigenetic profiles allow for more precise predictions in brain cancer

Scientists from the German Cancer Research Center (DKFZ) have analyzed the DNA methylation patterns in 500 ependymomas - tumors that occur in the brain and spinal cord. They were able to distinguish nine molecular subgroups. This classification enables clinicians to better predict the widely varying courses of disease that this type of cancer can take. In addition, key molecules in the various molecular groups have been identified as promising targets for more effective drug treatment in cases where chemotherapy is virtually ineffective.

No. 18 | 06. May 2015

CTS EVENTIM supports German Cancer Research Centre with one million Euro for an endowed chair

CTS EVENTIM supports German Cancer Research Centre with one million Euro for an endowed chair

CTS EVENTIM, Europe’s biggest provider of ticketing services, will finance an endowed chair in ‘Epigenetic Regulation’ at the German Cancer Research Centre (Deutsches Krebsforschungszentrum – DKFZ). The company will donate a total of one million Euro over a five-year period, according to a recent agreement concluded by Klaus-Peter Schulenberg, CEO of CTS EVENTIM, and the Management Board of the DKFZ.

Audio (in German only)
einblick (in German only)
Publications
Videos (in German only)
last update: 16/10/2013 back to top